Zenger News Since the October 7 Hamas attacks and the subsequent war in Gaza, some experts have been predicting doom-and-gloom for Israel's flourishing tech sector.\nSergey Gribov, a general partner of US-based...\n more…
Zacks Investment Research Compugen (CGEN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates...\n more…
PR Newswire Compugen to Present at Single Cell Genomics 2024 Conference Compugen to Present at Single Cell Genomics 2024 Conference PR Newswire HOLON, Israel, Sept. 9, 2024 HOLON, Israel, Sept. 9, 2024...\n more…
PR Newswire Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire HOLON, Israel, Aug...\n more…
Zacks Investment Research Investors might want to bet on Compugen (CGEN), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and...\n more…
Simply Wall St You may think that with a price-to-sales (or "P/S") ratio of 4.1x Compugen Ltd. ( NASDAQ:CGEN ) is definitely a stock...\n more…